Growth factor control of cultured rat uterine stromal cell proliferation is progesterone dependent

Biology of Reproduction

Volumn 55, Issue 6, 1996, Pages 1333-1342

  Piva, Marta ^a   Flieger, Oliver ^a   Rider, Virginia ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANTIGESTAGEN; BASIC FIBROBLAST GROWTH FACTOR; CYTOKERATIN; DESMIN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; MIFEPRISTONE; PLATELET DERIVED GROWTH FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; SURAMIN; TRANSFORMING GROWTH FACTOR ALPHA; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FETAL CALF SERUM; HORMONE DEPENDENCE; MITOSIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; STROMA CELL; UTERUS;

ANIMALIA; RODENTIA;

EID: 0029911514     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod55.6.1333     Document Type: Article

References (71)

1. Chang MC. Development and fate of transferred rabbit ova or blastocyst in relation to the ovulation time of recipients. J Exp Zool 1950; 114:197-225.
2. Psychoyos A. Uterine receptivity for nidation. Ann NY Acad Sci 1986; 476:36-42.
3. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
4. Martin L, Finn CA. Hormonal regulation of cell division in epithelial and connective tissues of the mouse uterus. J Endocrinol 1968; 41: 363-371.
5. Tachi C, Tachi S, Lindner HR. Modification by progesterone of estradiol-induced cell proliferation, RNA synthesis and estradiol distribution in the rat uterus. J Reprod Fertil 1972; 31:59-76.
6. Murray A, Hunt T. The Cell Cycle: An Introduction, 1st ed. New York: Oxford University Press; 1993: 89-116.
7. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990; 11:266-301.
8. Martin L, Finn CA, Trinder G. DNA synthesis in the endometrium of the progesterone-treated mice. J Endocrinol 1973; 41:363-371.
9. Weitlauf HM. Biology of implantation. In: Knobil E, Neill J, Ewing JJ, Greenwald GS, Markert CL, Pfaff DW (eds.), The Physiology of Reproduction. New York: Raven Press Ltd; 1988: 231-262.
10. Heap RB, Rider V, Wooding FBP, Flint APF. Molecular and cellular signaling and embryo survival. In: Sreenan JM. Diskin MG (eds.), Embryonic Mortality in Farm Animals. Dordretch: Martinus Nijhoff Publishers; 1986: 46-73.
11. Finn CA. Endocrine control of endometrial sensitivity during the induction of the decidual cell reaction in the mouse. J Endocrinol 1966; 36:239-248.
12. Galassi L. Autoradiographic study of the decidual cell reaction in the rat. Dev Biol 1968; 17:75-84.
13. Rider V, Wang M-Y, Finn CA, Heap RB, Feinstein A. Anti-fertility effect of passive immunization against progesterone is influenced by genotype. J Endocrinol 1986; 108:117-121.
14. Cullingford TE, Pollard JW. RU 486 completely inhibits the action of progesterone on cell proliferation in the mouse uterus. J Reprod Fertil 1988; 83:909-914.
15. Rider V, Psychoyos A. Inhibition of progesterone receptor function results in loss of basic fibroblast growth factor expression and stromal cell proliferation during uterine remodelling in the pregnant rat. J Endocrinol 1994; 140:239-249.
16. Guidice LC. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 1994; 61:1-17.
17. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 1992; 89:4658-4662.
18. Finn CA, Martin L. Patterns of cell division in the mouse uterus during early pregnancy. J Endocrinol 1967; 39:593-597.
19. Bigsby RM, Cunha GR. Effect of progestins and glucocorticoids on deoxyribonucleic acid synthesis in the uterus of the neonatal mice. Endocrinology 1985; 117:2520-2526.
20. Irwin JC, Utian WH, Eckert RL. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. Endocrinology 1991; 129:2385-2392.
21. Cohen H, Pageaux JF, Melinand C, Fayard JM, Laugier C. Normal rat uterine stromal cells in continuous culture: characterization and progestin regulation of growth. Eur J Cell Biol 1993; 61:116-125.
22. Chegini N, Rossi MJ, Masterson BJ. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF β-receptors in human endometrial tissue: localization and in vitro action. Endocrinology 1992; 130:2373-2385.
23. Hammond MG, Oh S-T, Anners J, Surrey ES, Halme J. The effect of growth factors on the proliferation of human endometrial stromal cells in culture. Am J Obstet Gynecol 1993; 168:1131-1138.
24. Mellor SJ, Thomas EJ. The actions of estradiol and epidermal growth factor in endometrial and endometriotic stroma in vitro. Fertil Steril 1994; 62:507-513.
25. Tang X-M, Rossi MJ, Masterson BJ, Chegini N. Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 1994; 50:1113-1125.
26. Massagué J, Roberts JM. Cell multiplication. Cell cycle 1995: constructing cell physiology with molecular building blocks. Curr Opin Cell Biol 1995; 7:769-772.
27. McCormack SA, Glasser SR. Differential response of individual uterine cell types from immature rats treated with estradiol. Endocrinology 1980; 106:1634-1649.
28. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
29. Tada H, Shibo O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin-2. J Immunol Methods 1986; 93:157-165.
30. Kitamura T, Tange T, Teresawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989; 140:323-334.
31. Lockwood CJ, Krikun G, Papp C, Aiger S, Nemerson Y, Schatz F. Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content. J Clin Endocrinol & Metab 1994; 79:786-790.
32. Narukawa S, Kanzaki H, Inoue T, Imai K, Higuchi T, Hatayama H, Kariya M, Mori T. Androgens induce prolactin production by human endometrial stromal cells in vitro. J Clin Endocrinol & Metab 1994; 78:165-168.
33. Steel RGD, Torrie JH. Analysis of variance I: the one-way classification. In: Principles and Procedures of Statistics, 1st ed. New York: McGraw-Hill Book Company; 1960: 99-131.
34. Carlone DL, Rider V. Embryonic modulation of basic fibroblast growth factor in the rat uterus. Biol Reprod 1993; 49:653-665.
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
36. Rider V, Piva M, Cohen ML, Carlone DL. Alternative splicing and differential targeting of fibroblast growth factor receptor 1 in the pregnant rat uterus. Endocrinology 1995; 136:3137-3145.
37. Beato M. Gene regulation by steroids hormones. Cell 1989; 56:335-344.
38. Johnson DE, Williams LT. Structural and functional diversity in the FGF multigene family. Adv Cancer Res 1993; 60:1-41.
39. Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, Bruner MW, Ryan JA, Marfia KE. Nature of the interaction of growth factors with suramin. Biochemistry 1992; 31:9016-9024.
40. Vignon F, Prebois C, Rochefort H. Inhibition of breast cancer growth by suramin. J Natl Cancer Inst 1992; 84:38-42.
41. Braddock PS, Hu D-E, Fan T-PD, Stratford IJ, Harris AL, Bicknell R. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions. Br J Cancer 1994; 69:890-898.
42. Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S. Suramin. an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 1994; 54:2654-2660.
43. Rago R, Mitchen J, Cheng A-L, Oberley T, Wilding G. Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res 1991; 51:6629-6635.
44. Aronica SM, Katzenellenbogen BS. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 1991; 128: 2045-2052.
45. Frost RA, Mazella J, Tseng L. Insulin-like growth factor binding protein-I inhibits the mitogenic effect of insulin-like growth factors and progestins in human endometrial stromal cells. Biol Reprod 1993; 49: 104-111.
46. Irwin JC, De las Fuentes L, Guidice LC. Growth factors and decidualization in vitro. Ann NY Acad Sci 1994; 734:7-18.
47. Prudovsky I, Savion N, Zhan X, Friesel R, Xu J, Hou J, McKeehan WL, Maciag T. Intact and functional fibroblast growth factor (FGF) receptor-I trafficks near the nucleus in response to FGF-I. J Biol Chem 1994; 269:31720-31724.
48. Prudovsky IA, Savion N, LaVallee TM, Maciag T. The FGF-I dependent intracellular traffick differential of FGFR-Iα and FGFR-Iβ. Mol Biol Cell 1995; 6S:124a.
49. Schrell UMH, Gauer S, Kiesewetter F, Bickel A, Hren J, Adams EF, Fahlbusch R. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extra-cellular growth factors, and PDGF-BB autocrine growth loop. J Neurosurg 1995; 82:600-607.
50. Michel P, Van Velthoven R, Metein M, Gras S, Etievant C, Pasteels JL, Kiss R. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures. Anticancer Res 1993; 11:2075-2078.
51. Rubio GJ, Pinedo HM, Virizuela J, van Ark-Otte J, Giaccone G. Effects of suramin on human lung cancer cell lines. Eur J Cancer 1995; 31A:244-251.
52. Kasayama S, Saito H, Kouhara H, Sumitani S, Sato B. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi Carcinoma 115) cells. J Cell Physiol 1992; 154:254-261.
53. Spigelman Z, Dowers A, Kennedy S, Disorbo D, O'Brien M, Barr R, McCaffrey R. Antiproliferative effects of suramin on lymphoid cells. Cancer Res 1987; 47:4694-4698.
54. Liaudet E, Derocq D, Rochefort H, Garcia M. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ 1995; 6:1045-1052.
55. Power RF, Lydon JP, Conneely OM, O'Malley BW. Dopamine activation of an orphan of the steroid receptor superfamily. Science 1991; 252:1546-1548.
56. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, Mclachlan JA. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993; 7:992-998.
57. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995; 81:541-550.
58. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9:383-391.
59. Lamb P, McKnight SL. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci 1991; 16:417-422.
60. Shibata F, Baird A, Florkiewicz RZ. Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 1991; 4:277-287.
61. Welsh AO, Enders AC. Light and electronmicroscopic examination of the mature decidual cell of the rat with emphasis on the antimesometrial decidua and its degeneration. Am J Anat 1985; 172:1-29.
62. Leroy F, Bogaert C, Van Hoeck J, Delcroix C. Cytophotometric and autoradiographic evaluation of cell kinetics in decidual growth in rats. J Reprod Fertil 1974; 38:441-449.
63. Finn CA, Lawn AM. Specialized junctions between decidual cells in the uterus of the pregnant mouse. J Ultrastruct Res 1967; 20:321-327.
64. Glasser SR, Julian J. Intermediate filament protein as a marker of uterine stromal cell decidualization. Biol Reprod 1986; 35:463-474.
65. Mani SK, Julian J, Lampelo S, Glasser SR. Initiation and maintenance of in vitro decidualization are independent of hormonal sensitization in vivo. Biol Reprod 1992; 47:785-799.
66. Glasser SK, Lampelo S, Munir IM, Julian J. Expression of desmin, laminin and fibronectin during in situ differentiation (decidualization) of rat uterine stromal cells. Differentiation 1987; 35:463-474.
67. Hochner-Celnikier D, Ron M, Eldor A, Segal S, Paltu Z, Fuks Z, Vlodavsky I. Growth characteristics of human first trimester decidual cells cultured in serum-free medium: production of prolactin, prostaglandins and fibronectin. Biol Reprod 1984; 31:827-836.
68. Gu Y, Gibori G. Isolation, culture and characterization of the two cell subpopulations forming the rat decidua: differential gene expression for activin, follistatin and decidual-related prolactin protein. Endocrinology 1995; 136:2451-2458.
69. Derynck R, Wagner E. Cell differentiation. Curr Opin Cell Biol 1995; 7:843-844.
70. Finn CA, Pope M, Milligan SR. Control of uterine stromal mitosis in relation to uterine sensitivity and decidualization in mice. J Reprod Fertil 1995; 103:153-158.
71. Arslan A, Guillermina A, Aingg HH. Characterization and co-culture of a novel nontransformed cell lines derived from rat endometrial epithelium and stroma. In Vitro Cell Dev Biol 1995; 31:140-148.